American Thoracic Society (ATS). American Thoracic Society Medical section of the American Lung Association Statement on Sarcoidosis This Joint Statement of the American Thoracic Society (ATS), The European Respiratory Society (ERS) and the World Association Of Sarcoidosis and other Graanulomatous Disorders (WASOG). 1999.

Giorgiutti S, Jacquot R, El Jammal T, Bert A, Jamilloux Y, Kodjikian L et al (2023) Sarcoidosis-related uveitis: a review. J Clin Med. https://doi.org/10.3390/jcm12093194

Article  PubMed  PubMed Central  Google Scholar 

Palmucci S, Emanuele Torrisi S, Carmelo Caltabiano D, Puglisi S, Lentini V, Grassedonio E et al (2016) Clinical and radiological features of extra-pulmonary sarcoidosis: a pictorial essay. Insights Imaging 7:571–587. https://doi.org/10.1594/ecr2015/C-2049

Article  PubMed  PubMed Central  Google Scholar 

Hamzeh N (2011) Sarcoidosis. Med Clin North Am 95:1223–1234. https://doi.org/10.1016/j.mcna.2011.08.004

Article  PubMed  Google Scholar 

Culver DA (2012) Sarcoidosis. Immunol Allergy Clin North Am 32:487–511. https://doi.org/10.1016/j.iac.2012.08.005

Article  PubMed  Google Scholar 

Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J (2014) Sarcoidosis. The Lancet, vol 383. Elsevier

Google Scholar 

Judson MA (2007) Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 28:83–101. https://doi.org/10.1055/s-2007-970335

Article  PubMed  Google Scholar 

Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S et al (2021) Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. https://doi.org/10.3390/cells10040766

Article  PubMed  PubMed Central  Google Scholar 

Rochepeau C, Jamilloux Y, Kerever S, Febvay C, Perard L, Broussolle C et al (2017) Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol 101:856–861. https://doi.org/10.1136/bjophthalmol-2016-309767

Article  PubMed  Google Scholar 

Bodaghi B, Touitou V, Fardeau C, Chapelon C, LeHoang P (2012) Ocular sarcoidosis. Presse Medicale. https://doi.org/10.1016/j.lpm.2012.04.004

Article  PubMed  Google Scholar 

Umur KA, Tayfun B, Oguzhan O (2012) Different ophthalmologic manifestations of sarcoidosis. Curr Opin Ophthalmol 23:477–484. https://doi.org/10.1097/ICU.0b013e328358c7a6

Article  PubMed  Google Scholar 

Phillips YL, Eggenberger ER (2010) Neuro-ophthalmic sarcoidosis. Curr Opin Ophthalmol 21:423–429. https://doi.org/10.1097/ICU.0b013e32833eae4d

Article  PubMed  Google Scholar 

Crick RP, Hoyle C, Smellie H (1961) The eyes in Sarcoidosis.

Pasadhika S, Rosenbaum JT (2015) Ocular sarcoidosis. Clin Chest Med 36:669–683. https://doi.org/10.1016/j.ccm.2015.08.009

Article  PubMed  PubMed Central  Google Scholar 

Bonfioli AA, Orefice F (2005) Sarcoidosis. Semin Ophthalmol 20:177–182. https://doi.org/10.1080/08820530500231938

Article  PubMed  Google Scholar 

Paovic J, Paovic P, Sredovic V, Jovanovic S (2018) Clinical manifestations, complications and treatment of ocular sarcoidosis: correlation between visual efficiency and macular edema as seen on optical coherence tomography. Semin Ophthalmol 33:202–209. https://doi.org/10.1080/08820538.2016.1206576

Article  Google Scholar 

Crickx E, Machelart I, Lazaro E, Kahn JE, Cohen-Aubart F, Martin T et al (2016) intravenous immunoglobulin as an immunomodulating agent in antineutrophil cytoplasmic antibody-associated vasculitides: a french nationwide study of ninety-two patients. Arthritis and Rheumatology 68:702–712. https://doi.org/10.1002/art.39472

Article  CAS  PubMed  Google Scholar 

Holmes J, Lazarus A (2009) Sarcoidosis: extrathoracic manifestations. Dis Mon 55:675–692. https://doi.org/10.1016/j.disamonth.2009.05.002

Article  PubMed  Google Scholar 

Jabs DA, Johns CJ (1986) Ocular Involvement in Chronic Sarcoidosis. vol. 102.

Tempest-Roe S, Joshi L, Dick AD, Taylor SR (2013) Local therapies for inflammatory eye disease in translation: Past, present and future. BMC Ophthalmol. https://doi.org/10.1186/1471-2415-13-39

Article  PubMed  PubMed Central  Google Scholar 

Cabrera M, Yeh S, Albini TA (2014) Sustained-release corticosteroid options. J Ophthalmol. https://doi.org/10.1155/2014/164692

Article  PubMed  PubMed Central  Google Scholar 

Salek SS, Leder HA, Butler NJ, Gan TJ, Dunn JP, Thorne JE (2013) Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis. Ocul Immunol Inflamm 21:257–263. https://doi.org/10.3109/09273948.2013.767353

Article  CAS  PubMed  Google Scholar 

Duica I, Voinea L-M, Mitulescu C, Istrate S, Coman I-C, Ciuluvica R (2018) The use of biologic therapies in uveitis. Rom J Ophthalmol 61:105–113. https://doi.org/10.22336/rjo.2018.16

Article  Google Scholar 

Baughman RP, Costabel U, du Bois RM (2008) Treatment of Sarcoidosis. Clin Chest Med 29:533–548. https://doi.org/10.1016/j.ccm.2008.03.012

Article  PubMed  Google Scholar 

Iannuzzi MC, Rybicki BA, Teirstein AS. (2007) Sarcoidosis. vol. 357. 2007.

Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT et al (2009) Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. https://doi.org/10.1016/j.ajo.2009.05.008

Article  PubMed  PubMed Central  Google Scholar 

Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E et al (2014) A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology 121:1863–1870. https://doi.org/10.1016/j.ophtha.2014.04.023

Article  PubMed  Google Scholar 

Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB et al (2010) Cyclosporine for ocular inflammatory diseases. Ophthalmology 117:576–584. https://doi.org/10.1016/j.ophtha.2009.08.010

Article  PubMed  Google Scholar 

Jaffe GJ, Dick AD, Brézin AP, Nguyen QD, Thorne JE, Kestelyn P et al (2016) Adalimumab in patients with active noninfectious uveitis. N Engl J Med 375:932–943. https://doi.org/10.1056/nejmoa1509852

Article  CAS  PubMed  Google Scholar 

Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J et al (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. The Lancet 388:1183–1192. https://doi.org/10.1016/S0140-6736(16)31339-3

Article  CAS  Google Scholar 

Riancho-Zarrabeitia L, Calvo-Río V, Blanco R, Mesquida M, Adan AM, Herreras JM et al (2015) Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: multicenter study of 17 patients. Semin Arthritis Rheum 45:361–368. https://doi.org/10.1016/j.semarthrit.2015.05.010

Article  CAS  PubMed  Google Scholar 

Suhler EB, Lowder CY, Goldstein DA, Giles T, Lauer AK, Kurz PA et al (2013) Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial. Br J Ophthalmol 97:481–486. https://doi.org/10.1136/bjophthalmol-2012-302292

Article  PubMed  Google Scholar 

Ogbue OD, Malhotra P, Akku R, Jayaprakash T, Khan S (2020) Biologic therapies in sarcoidosis and uveitis: a review. Cureus. https://doi.org/10.7759/cureus.9057

Article  PubMed  PubMed Central  Google Scholar 

Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L et al (2016) Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the french uveitis network. Arthritis and Rheumatology 68:1522–1530. https://doi.org/10.1002/art.39667

Article  CAS  PubMed  Google Scholar 

Cottin V (2010) Update on bioagent therapy in sarcoidosis. F1000 Med Rep 2:13. https://doi.org/10.3410/M2-13

Article  PubMed